PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Paclitaxel
Presentation Product Chemical substance Chapter Items dispensed
Paclitaxel 100mg/16.7ml solution for infusion vials
0801050V0AAABAB
Paclitaxel Paclitaxel Malignant Disease and Immunosuppression No data available
Paclitaxel 150mg/25ml solution for infusion vials
0801050V0AAACAC
Paclitaxel Paclitaxel Malignant Disease and Immunosuppression No data available
Paclitaxel 300mg/50ml solution for infusion vials
0801050V0AAADAD
Paclitaxel Paclitaxel Malignant Disease and Immunosuppression No data available
Paclitaxel 30mg/5ml solution for infusion vials
0801050V0AAAAAA
Paclitaxel Paclitaxel Malignant Disease and Immunosuppression No data available
Paxene 100mg/16.7ml solution for infusion vials
0801050V0BCABAB
Paxene Paclitaxel Malignant Disease and Immunosuppression No data available
Paxene 150mg/25ml solution for infusion vials
0801050V0BCACAC
Paxene Paclitaxel Malignant Disease and Immunosuppression No data available
Paxene 300mg/50ml solution for infusion vials
0801050V0BCADAD
Paxene Paclitaxel Malignant Disease and Immunosuppression No data available
Paxene 30mg/5ml solution for infusion vials
0801050V0BCAAAA
Paxene Paclitaxel Malignant Disease and Immunosuppression No data available
Taxol 100mg/16.7ml solution for infusion vials
0801050V0BBABAB
Taxol Paclitaxel Malignant Disease and Immunosuppression No data available
Taxol 150mg/25ml solution for infusion vials
0801050V0BBADAC
Taxol Paclitaxel Malignant Disease and Immunosuppression No data available
Taxol 300mg/50ml solution for infusion vials
0801050V0BBACAD
Taxol Paclitaxel Malignant Disease and Immunosuppression No data available
Taxol 30mg/5ml solution for infusion vials
0801050V0BBAAAA
Taxol Paclitaxel Malignant Disease and Immunosuppression No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.